By Mill Chart
Last update: Jul 30, 2025
Alignment Healthcare Inc (NASDAQ:ALHC) delivered a strong second-quarter performance for 2025, surpassing analyst expectations on both revenue and earnings per share (EPS). The company’s results triggered a sharp positive market reaction, with shares rising more than 20% in after-hours trading.
The stock surged 15.4% in after-hours trading following the earnings release, reflecting investor optimism. This follows a relatively flat performance over the past month (-8.5%) and a slight decline in the last two weeks (-2.9%). The sharp rebound suggests that the market had not fully priced in the company’s improved profitability and revenue acceleration.
Alignment Healthcare raised its full-year outlook, signaling confidence in continued growth. While specific guidance figures were not detailed in the press release, the company’s Q3 revenue midpoint projection of $977.5 million is 2.1% above analyst expectations.
For the full year, analysts had estimated a revenue decline of 0.35%, but the company’s upward revision suggests stronger performance than initially anticipated. Similarly, the EPS outlook appears to be improving, given the Q2 beat and management’s optimistic tone.
For more detailed earnings estimates and historical performance, visit Alignment Healthcare’s earnings page.
Disclaimer: This article is not investment advice. Investors should conduct their own research or consult a financial advisor before making decisions.